Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome

NCT07114055 is registered in ClinicalTrials.gov with Md. Hazrat Ali as lead sponsor.

NCT NCT07114055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07114055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Lead sponsor
Md. Hazrat Ali
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 15, 2025
Completion date
July 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome - diarrhoea